SCM
KRYS icon

Silverarc Capital Management’s Krystal Biotech KRYS Stock Holding History

Silverarc Capital Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,000
Closed -$1.78M – 80
2024
Q1 		$1.78M Buy
+10,000
New +$1.39M 0.5% 51
2023
Q4 		– Sell
-71,531
Closed -$8.3M – 80
2023
Q3 		$8.3M Sell
71,531
-47,410
-40% -$5.78M 3.09% 11
2023
Q2 		$14M Buy
118,941
+84,927
+250% +$8.67M 4.71% 5
2023
Q1 		$2.72M Sell
34,014
-24,521
-42% -$1.93M 1.22% 33
2022
Q4 		$4.64M Buy
58,535
+1,890
+3% +$140K 1.6% 28
2022
Q3 		$3.95M Sell
56,645
-48,632
-46% -$3.51M 1.67% 28
2022
Q2 		$6.91M Buy
105,277
+58,788
+126% +$3.66M 3.24% 17
2022
Q1 		$3.09K Sell
46,489
-181
-0.4% -$11.3K 1.46% 18
2021
Q4 		$3.27M Buy
+46,670
New +$2.72M 1.46% 23

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return